Microglia in ALS: The Good, The Bad, and The Resting

Overview of attention for article published in Journal of Neuroimmune Pharmacology, September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 281 Dimensions

Readers on

mendeley: 325 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases

Grant US-11905258-B2

United States of America

2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases

Grant US-11718593-B2

United States of America

2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases

Grant US-11472781-B2

United States of America

Materials and methods for diagnosis and treatment of Alzheimer's disease

Grant US-10718785-B2

United States of America

Micrornas in neurodegenerative disorders

Grant US-10184151-B2

United States of America

Rho kinase inhibitors for use in treating familial amyotrophic lateral sclerosis

Grant US-9980972-B2

United States of America

METHOD FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS BY INHIBITION OF CXCR4/CXCL12 SIGNALING

Application WO-2015031722-A1

World Intellectual Property Organisation (WIPO)

RHO KINASE INHIBITORS FOR USE IN TREATING AMYOTROPHIC LATERAL SCLEROSIS

Application WO-2013135596-A1

World Intellectual Property Organisation (WIPO)